Influence of targeted exercise therapy on quality of life in patients after condition with peri- and postoperative uveamelanoma. - EyeCanMoveiT

niversitätsklinikum Köln0 个研究点目标入组 75 人开始时间: 2023年2月3日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Diagnosis of uveamelanoma; prior to first-line oncologic therapy, radiotherapy (cyberknife) or enucleation; curative medical treatment approach or life expectancy at least 6 months; good German language skills; written informed consent.

•- Failure to meet inclusion criteria
•- Shortened life expectancy of less than 6 months
•- All general diseases that do not allow sports activity in particular:
•o Clinical-manifest heart failure (NYHA III-IV).
•o Respiratory partial or global insufficiency
•o Permanent thrombocytopenia <10,000/µl, e.g., refractory autoimmune thrombocytopenia
•o Congenital or acquired thrombocytopathies or coagulation disorders.
•o Symptomatic CHD (clearance certificate required, stress ECG and cardiac ultrasound recommended if necessary)
•o Severe refractory hypertension
•o Uncontrollable COPD
•o Uncontrolled cerebral seizure disorder
•o Severe anemia (requiring transfusion).
•- Medical or mental condition that, in the opinion of the investigator, does not allow the patient to participate in the study or provide a legally binding signature on the informed consent form
•- Lack of willingness to store and share personal medical records as part of the protocol
•- Participation in another exercise therapy study

发起方

niversitätsklinikum Köln